Role of sentinel surveillance of candidemia: trends in species distribution and antifungal susceptibility.
about
Drug Resistance Is Not Directly Affected by Mating Type Locus Zygosity in Candida albicansDelaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortalitySurface glycans of Candida albicans and other pathogenic fungi: physiological roles, clinical uses, and experimental challenges.Protease expression by microorganisms and its relevance to crucial physiological/pathological eventsA new tool to quantify receptor recruitment to cell contact sites during host-pathogen interactionRapid identification of medically important Candida isolates using high resolution melting analysisEpidemiology of invasive candidiasis: a persistent public health problemCell wall mannan and cell surface hydrophobicity in Candida albicans serotype A and B strains.Results from the ARTEMIS DISK Global Antifungal Surveillance Study: a 6.5-year analysis of susceptibilities of Candida and other yeast species to fluconazole and voriconazole by standardized disk diffusion testing.Variation in susceptibility of bloodstream isolates of Candida glabrata to fluconazole according to patient age and geographic locationPhenotypic and molecular characterization of Candida nivariensis sp. nov., a possible new opportunistic fungusActivities of available and investigational antifungal agents against rhodotorula speciesCandidaemia and antifungal therapy in a French University Hospital: rough trends over a decade and possible links.Uniform distribution of three Candida albicans microsatellite markers in two French ICU populations supports a lack of nosocomial cross-contamination.Epidemiology and predictors of mortality in cases of Candida bloodstream infection: results from population-based surveillance, barcelona, Spain, from 2002 to 2003.Occurrence of Candida orthopsilosis in Brazilian tomato fruits (Lycopersicum esculentum Mill.).Efficacy, plasma pharmacokinetics, and safety of icofungipen, an inhibitor of Candida isoleucyl-tRNA synthetase, in treatment of experimental disseminated candidiasis in persistently neutropenic rabbits.Candidemia in patients with prolonged fever in Kashan, Iran.Antifungal susceptibilities of Candida species causing vulvovaginitis and epidemiology of recurrent cases.Global trends in the antifungal susceptibility of Cryptococcus neoformans (1990 to 2004).Risk factors for fluconazole-resistant Candida glabrata bloodstream infectionsDirect maldi-tof mass spectrometry assay of blood culture broths for rapid identification of Candida species causing bloodstream infections: an observational study in two large microbiology laboratoriesCanadian clinical practice guidelines for invasive candidiasis in adults.Correlation of MIC with outcome for Candida species tested against voriconazole: analysis and proposal for interpretive breakpoints.Interpretive breakpoints for fluconazole and Candida revisited: a blueprint for the future of antifungal susceptibility testingEpidemiology, risk factors, and prognosis of Candida parapsilosis bloodstream infections: case-control population-based surveillance study of patients in Barcelona, Spain, from 2002 to 2003.Candida guilliermondii fungemia in patients with hematologic malignanciesFKS2 mutations associated with decreased echinocandin susceptibility of Candida glabrata following anidulafungin therapy.In vitro activities of voriconazole, posaconazole, and four licensed systemic antifungal agents against Candida species infrequently isolated from blood.Evaluation of Etest method for determining fluconazole and voriconazole MICs for 279 clinical isolates of Candida species infrequently isolated from bloodA small subpopulation of blastospores in candida albicans biofilms exhibit resistance to amphotericin B associated with differential regulation of ergosterol and beta-1,6-glucan pathway genes.Risk factors for candida infection of the genital tract in the tropics.Systemic antifungal therapy: new options, new challenges.Geographic variation in the susceptibilities of invasive isolates of Candida glabrata to seven systemically active antifungal agents: a global assessment from the ARTEMIS Antifungal Surveillance Program conducted in 2001 and 2002.Cross-resistance between fluconazole and ravuconazole and the use of fluconazole as a surrogate marker to predict susceptibility and resistance to ravuconazole among 12,796 clinical isolates of Candida sppFurther standardization of broth microdilution methodology for in vitro susceptibility testing of caspofungin against Candida species by use of an international collection of more than 3,000 clinical isolates.Evaluation of VITEK 2 and RapID yeast plus systems for yeast species identification: experience at a large clinical microbiology laboratoryChoices aplenty: antifungal prophylaxis in hematopoietic stem cell transplant recipients.Results from the ARTEMIS DISK Global Antifungal Surveillance study, 1997 to 2005: an 8.5-year analysis of susceptibilities of Candida species and other yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testMicafungin: the US perspective.
P2860
Q22337052-B2F80B5B-122E-4F04-8146-CE4BAA5C9E07Q24530412-F89A7936-C060-4A4E-86DE-D13A8501E4D1Q24625384-8560B127-4051-4AB8-90CB-CCC450738F80Q28477918-87C52CC8-7C73-4D9E-88DD-E9B7B572DB1AQ28539165-80E3376C-CA90-4B9D-9913-E0B023481CA5Q28543415-752CF665-FC8F-4BF1-870D-C92DB7CB1A2CQ29616758-A10802A3-8A2B-42CF-9CAD-AA22E5232B14Q30434895-3835F0DB-F35A-4AB5-988E-28FE7B045A11Q30447051-BDF3825A-FA75-4A92-B604-FF1E7C649B8FQ30452976-11EC5BAD-E89A-485C-A441-CF2319C97E52Q30998443-744C92D9-6738-4D9C-8FB6-3338889AF331Q33210616-8010798C-44F5-41F2-9B7A-BF0269C12075Q33241991-B973AAD7-50C4-432F-81C0-9F171587A021Q33263440-923B6F53-2754-4801-83A7-21EFB2E9A8C4Q33753405-B6BAF92B-C3AD-4925-91A9-4C8B279DFBA1Q33761880-5078B70C-4EC4-45CF-BB34-BE137E27591AQ33770019-2C110FD6-77CE-4667-9646-019AB5A3EFA6Q33851292-C033CA81-256A-48B9-A04F-1F28A5F08C7AQ33859133-A0413A5F-3FC5-4E15-AA51-F1560C745647Q33859215-EF73F562-BC3E-4CAC-9C46-B90C4F068C96Q33932340-8ADC430D-FCDF-4062-9536-71029C4E9D81Q34076344-758915EC-F392-4248-8CF8-FEF496D79B8AQ34237335-38D083C0-0C94-4941-B6BE-8E1849FC5183Q34431984-1133EB9B-E6D9-431C-B7D9-9F205D2AD07CQ34647337-665BCF7A-C3CE-4022-83EF-525035D5B9BDQ34680777-C64DF7BA-E078-4360-80BB-ED35A2C4FBBCQ34719843-F8A85556-F938-4B39-992C-F90A6E3CAA53Q34737334-6069B877-7CBC-403A-9E14-4F0B4BD11450Q34749162-60DA0773-D598-4C70-AE08-12E67AF41DE8Q34774859-E5D8A3AA-4617-4D6B-A351-FCF5B5E3AE1AQ35127891-E41BBAFA-AE89-4F55-9286-6A15142688EAQ35207143-2641C86B-9A9C-4320-80F2-C30417525E61Q35585219-0000D48A-51A4-4B38-9279-319C0A8C4E1AQ35714132-B7D64A85-27B2-49F5-9610-C35CE05C1408Q35714264-75E5690B-7A28-4A40-8DB3-BD74F43413F5Q35718542-90423082-72D9-421E-9709-7DBA300D759BQ35784345-D567E7A0-22C6-4FA9-A186-1E8C8ABCD512Q35833407-28C07AB3-8658-40C3-A1AC-F2A6E86097BDQ35913918-97FA46B6-2B64-4618-961A-E237E274934EQ36140652-78AE4F57-1A15-424E-AF29-F4DBD3F22D1A
P2860
Role of sentinel surveillance of candidemia: trends in species distribution and antifungal susceptibility.
description
2002 nî lūn-bûn
@nan
2002 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Role of sentinel surveillance ...... and antifungal susceptibility.
@ast
Role of sentinel surveillance ...... and antifungal susceptibility.
@en
Role of sentinel surveillance ...... and antifungal susceptibility.
@nl
type
label
Role of sentinel surveillance ...... and antifungal susceptibility.
@ast
Role of sentinel surveillance ...... and antifungal susceptibility.
@en
Role of sentinel surveillance ...... and antifungal susceptibility.
@nl
prefLabel
Role of sentinel surveillance ...... and antifungal susceptibility.
@ast
Role of sentinel surveillance ...... and antifungal susceptibility.
@en
Role of sentinel surveillance ...... and antifungal susceptibility.
@nl
P2860
P1476
Role of sentinel surveillance ...... and antifungal susceptibility.
@en
P2093
D J Diekema
M A Pfaller
P2860
P304
P356
10.1128/JCM.40.10.3551-3557.2002
P407
P577
2002-10-01T00:00:00Z